Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sea Limited
SE
|
+$1.96B |
| 2 |
AbbVie
ABBV
|
+$1.42B |
| 3 |
D.R. Horton
DHI
|
+$783M |
| 4 |
Amazon
AMZN
|
+$603M |
| 5 |
Eli Lilly
LLY
|
+$586M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.18B |
| 2 |
EOG Resources
EOG
|
+$999M |
| 3 |
JPMorgan Chase
JPM
|
+$874M |
| 4 |
Comcast
CMCSA
|
+$746M |
| 5 |
TC Energy
TRP
|
+$626M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.11% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Industrials | 10.84% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
B
251
Barrick Mining
B
$66.7B
| $116M | 0.04% |
7,487,963
+1,488
| +0% | +$23.5K |
|
252
Guardant Health
GH
$22.1B
| $116M | 0.04% |
2,150,504
+1,171
| +0.1% | +$60.1K |
|
253
NXP Semiconductors
NXPI
$59B
| $114M | 0.04% |
776,104
+11,438
| +1% | +$1.92M |
|
254
Pegasystems
PEGA
$5.17B
| $114M | 0.04% |
7,071,900
+335,798
| +5% | +$6.83M |
|
255
Cigna
CI
$73.8B
| $111M | 0.04% |
398,684
-9
| -0% | -$2.53K |
|
256
Chegg
CHGG
$87.2M
| $109M | 0.04% |
5,179,666
+2,075
| +0% | +$43K |
|
257
TPG
TPG
$8.2B
| $106M | 0.03% |
3,792,907
+1,286
| +0% | +$37.2K |
|
258
Coupang
CPNG
$29B
| $102M | 0.03% |
6,095,806
-96,999
| -2% | -$1.68M |
|
259
Asbury Automotive
ABG
$3.77B
| $102M | 0.03% |
672,430
-88,672
| -12% | -$15.1M |
|
260
Shell
SHEL
$247B
| $98.8M | 0.03% |
1,985,299
-1,104,957
| -36% | -$56.9M |
|
|
SMAR
261
DELISTED
Smartsheet Inc.
SMAR
| $96.9M | 0.03% |
2,820,948
+1,993,848
| +241% | +$67.6M |
|
262
Petrobras
PBR
$114B
| $96.9M | 0.03% |
7,851,629
+324,196
| +4% | +$4.29M |
|
263
Credo Technology Group
CRDO
$51.8B
| $96.3M | 0.03% |
8,750,082
| – | – |
|
264
Corebridge Financial
CRBG
$15.1B
| $95.4M | 0.03% |
+4,846,446
| New | +$99.7M |
|
265
Marvell Technology
MRVL
$201B
| $94.8M | 0.03% |
2,209,473
+2,045,865
| +1,250% | +$101M |
|
266
Nutrien
NTR
$31.9B
| $93.2M | 0.03% |
1,118,060
-2,013,238
| -64% | -$173M |
|
267
Infosys
INFY
$49.7B
| $93.1M | 0.03% |
+5,486,519
| New | +$103M |
|
268
Trane Technologies
TT
$105B
| $93M | 0.03% |
642,447
-161
| -0% | -$24.1K |
|
269
SS&C Technologies
SSNC
$18.9B
| $92.9M | 0.03% |
1,946,436
+881
| +0% | +$50.7K |
|
270
ResMed
RMD
$32.5B
| $91.9M | 0.03% |
420,868
-103,604
| -20% | -$23.6M |
|
271
Extra Space Storage
EXR
$31.4B
| $90.3M | 0.03% |
522,996
+614
| +0.1% | +$116K |
|
|
EVRI
272
DELISTED
Everi Holdings
EVRI
| $89.5M | 0.03% |
5,517,986
-2,240,452
| -29% | -$41.3M |
|
273
PAR Technology
PAR
$749M
| $87.9M | 0.03% |
2,977,672
| – | – |
|
|
CCC
274
CCC Intelligent Solutions
CCC
$4.11B
| $87.7M | 0.03% |
9,639,749
-43,791
| -0.5% | -$414K |
|
275
Black Hills Corp
BKH
$5.66B
| $87.4M | 0.03% |
1,290,379
+696,279
| +117% | +$52.2M |
|
Similar funds
Capital Research Global Investors's Q3 2022 Portfolio in Review
As of Q3 2022, Capital Research Global Investors held 452 positions worth $304B, down 5.2% from $321B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Capital Research Global Investors's Q3 2022 filing shows 29 new, 189 increased, 162 reduced and 23 closed positions. Its largest new stake was Centene: 2,829,733 shares worth $220M. The largest sale was Canadian Natural Resources, an estimated $1.18B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q3 2022 buy was Centene: 2,829,733 shares worth $220M.
- Capital Research Global Investors added most to Sea Limited in Q3 2022, an estimated $1.96B increase.
- Capital Research Global Investors's biggest Q3 2022 reduction was Canadian Natural Resources, cutting an estimated $1.18B.
- Capital Research Global Investors fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q3 2022, selling an estimated $210M.
- Capital Research Global Investors's ten largest holdings make up 28% of its $304B portfolio in Q3 2022.
- Capital Research Global Investors opened 29 new positions and closed 23 in Q3 2022.
- Capital Research Global Investors's portfolio value fell 5.2% quarter-over-quarter to $304B.
Based on Capital Research Global Investors's 13F filing for Q3 2022, filed 14 Nov 2022.